|
||||
|
|
|
Contents |
|
|
|
|
| Epidemiology & Risk Factors | |
| Etiology & Pathogenesis | |
| Integrative Medicine | |
| Overall Management | |
| Treatment | |
|
|
|
|
|
|
|
|
|
|
Preston-Martin
S, Pogoda JM, Mueller BA, Lubin F, Modan B, Holly EA, Filippini G,
Cordier S, Peris-Bonet R, Choi W, Little J, Arslan A Prenatal vitamin supplementation and pediatric brain tumors: huge international variation in use and possible reduction in risk Childs Nerv Syst. 1998 Oct;14(10):551-7. |
|
|
|
|
|
|
|
|
|
|
|
Kaplan
S, Novikov I, Modan B Nutritional factors in the etiology of brain tumors: potential role of nitrosamines, fat, and cholesterol Am J Epidemiol. 1997 Nov 15;146(10):832-41. |
|
|
|
|
|
|
|
|
|
|
|
Gramaglia A, Loi GF, Mongioj V, Baronzio GF Increased survival in brain metastatic patients treated with stereotactic radiotherapy, omega three fatty acids and bioflavonoids Anticancer Res. 1999 Nov-Dec;19(6C):5583-6. |
|
|
Liat
Lomnitski, Margalit Bergman, Abraham Nyska, Varda Ben-Shaul, Shlomo Grossman Composition, Efficacy, and Safety of Spinach Extracts Nutrition and Cancer, Volume: 46 Number: 2 Page: 222 -- 231 (December 2003) |
|
|
Montfort H |
|
|
|
|
|
|
|
|
|
|
|
Lisa
M. DeAngelis
|
|
|
Hau
P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, Fabel K, Grauer
O, Wismeth C, Klinkhammer-Schalke M, Allgauer M, Schuierer G, Koch H,
Schlaier J, Ulrich W, Brawanski A, Bogdahn U, Steinbrecher A Salvage therapy in patients with glioblastoma: is there any benefit? Cancer. 2003 Dec 15;98(12):2678-86. |
|
|
Stephen B.
Tatter, M.D., Ph.D. |
|
|
McWilliams
RR, Brown PD, Buckner JC, Link MJ, Markovic SN Treatment of brain metastases from melanoma Mayo Clin Proc. 2003 Dec;78(12):1529-36. |
|
|
|
|
|
|
|
|
|
|
|
Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy Journal of Clinical Oncology, Vol 21, Issue 24 (December), 2003: 4489-4495 |
|
|
High-Dose Methotrexate-Based Chemotherapy Followed by Consolidating Radiotherapy in Non–AIDS-Related Primary Central Nervous System Lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962 Journal of Clinical Oncology, Vol 21, Issue 24 (December), 2003: 4483-4488 |
|
